Enliven Therapeutics
Discovering and developing next generation precision oncology therapeutics.
HQ location
Boulder, United States
Website
Launch date
Employees
Market cap
$1.2b
loading funding rounds…
Roche(exited)
OrbiMed(exited)
5AM Ventures(exited)
Logos Capital(exited)
Tavistock Group(exited)
Janus Henderson Investors(exited)
Citadel(exited)
Frazier Healthcare Partners(exited)
RA Capital Management(exited)
Fidelity Investments(exited)
Sheatree Capital(exited)
Boxer Capital(exited)
Surveyor Capital(exited)
Commodore Capital(exited)
Fairmount Funds Management(exited)
Cormorant Asset Management(exited)
Roche Venture Fund(exited)
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Enliven Therapeutics
Edit
ACQUISITION by Enliven Therapeutics Oct 2022